Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Therapeutic Antibodies Targeting CSF1 Impede Macrophage Recruitment in a Xenograft Model of Tenosynovial Giant Cell Tumor.

Cheng H, Clarkson PW, Gao D, Pacheco M, Wang Y, Nielsen TO.

Sarcoma. 2010;2010:174528. doi: 10.1155/2010/174528. Epub 2010 Oct 13.

2.

Macrophage diversity enhances tumor progression and metastasis.

Qian BZ, Pollard JW.

Cell. 2010 Apr 2;141(1):39-51. doi: 10.1016/j.cell.2010.03.014. Review.

3.

Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.

Espinosa I, Beck AH, Lee CH, Zhu S, Montgomery KD, Marinelli RJ, Ganjoo KN, Nielsen TO, Gilks CB, West RB, van de Rijn M.

Am J Pathol. 2009 Jun;174(6):2347-56. doi: 10.2353/ajpath.2009.081037. Epub 2009 May 14.

4.

M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis.

Kubota Y, Takubo K, Shimizu T, Ohno H, Kishi K, Shibuya M, Saya H, Suda T.

J Exp Med. 2009 May 11;206(5):1089-102. doi: 10.1084/jem.20081605. Epub 2009 Apr 27.

5.

The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.

Allavena P, Sica A, Garlanda C, Mantovani A.

Immunol Rev. 2008 Apr;222:155-61. doi: 10.1111/j.1600-065X.2008.00607.x. Review.

PMID:
18364000
6.

Prognostic significance of macrophage infiltration in leiomyosarcomas.

Lee CH, Espinosa I, Vrijaldenhoven S, Subramanian S, Montgomery KD, Zhu S, Marinelli RJ, Peterse JL, Poulin N, Nielsen TO, West RB, Gilks CB, van de Rijn M.

Clin Cancer Res. 2008 Mar 1;14(5):1423-30. doi: 10.1158/1078-0432.CCR-07-1712.

7.

The Stanford Tissue Microarray Database.

Marinelli RJ, Montgomery K, Liu CL, Shah NH, Prapong W, Nitzberg M, Zachariah ZK, Sherlock GJ, Natkunam Y, West RB, van de Rijn M, Brown PO, Ball CA.

Nucleic Acids Res. 2008 Jan;36(Database issue):D871-7. Epub 2007 Nov 7.

8.

Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes.

Gratzinger D, Zhao S, Marinelli RJ, Kapp AV, Tibshirani RJ, Hammer AS, Hamilton-Dutoit S, Natkunam Y.

Am J Pathol. 2007 Apr;170(4):1362-9.

9.

Markers of angiogenesis and clinical features in patients with sarcoma.

DuBois S, Demetri G.

Cancer. 2007 Mar 1;109(5):813-9. Review.

10.

Macrophages regulate the angiogenic switch in a mouse model of breast cancer.

Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN, Pollard JW.

Cancer Res. 2006 Dec 1;66(23):11238-46. Epub 2006 Nov 17.

11.

Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.

Condeelis J, Pollard JW.

Cell. 2006 Jan 27;124(2):263-6. Review.

12.

Distinct role of macrophages in different tumor microenvironments.

Lewis CE, Pollard JW.

Cancer Res. 2006 Jan 15;66(2):605-12. Review.

13.

Microvessel density does not predict outcome in high grade soft tissue sarcoma.

West CC, Brown NJ, Mangham DC, Grimer RJ, Reed MW.

Eur J Surg Oncol. 2005 Dec;31(10):1198-205. Epub 2005 Jun 29.

PMID:
15993027
14.

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.

Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA.

Cell. 2005 May 6;121(3):335-48.

15.

Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models.

Lee CH, Xue H, Sutcliffe M, Gout PW, Huntsman DG, Miller DM, Gilks CB, Wang YZ.

Gynecol Oncol. 2005 Jan;96(1):48-55.

PMID:
15589579
16.

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays.

Liu CL, Prapong W, Natkunam Y, Alizadeh A, Montgomery K, Gilks CB, van de Rijn M.

Am J Pathol. 2002 Nov;161(5):1557-65.

17.
18.

Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas.

Yudoh K, Kanamori M, Ohmori K, Yasuda T, Aoki M, Kimura T.

Br J Cancer. 2001 Jun 15;84(12):1610-5.

19.

Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR.

Cancer Res. 1999 Oct 1;59(19):5002-11.

20.

Neovascularity and clinical outcome in high-grade extremity soft tissue sarcomas.

Saenz NC, Heslin MJ, Adsay V, Lewis JJ, Leung DH, LaQuaglia MP, Brennan MF.

Ann Surg Oncol. 1998 Jan-Feb;5(1):48-53.

PMID:
9524708

Supplemental Content

Support Center